The efficiency of risedronate in reducing bone resorption after total hip arthroplasty: a meta-analysis of randomized control trials at a minimum of 6 months’ follow-up
Abstract Background Recently risedronate is suggested to be effective for the prevention and treatment of for osteoporosis in total hip arthroplasty. This meta-analysis aimes to evaluate the efficacy of risedronate in reducing femoral periprosthetic bone mineral density loss in patients undergoing p...
Main Author: | Liqing Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-04-01
|
Series: | Journal of Orthopaedic Surgery and Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13018-018-0808-z |
Similar Items
-
Oral risedronate increases Gruen zone bone mineral density after primary total hip arthroplasty: a meta-analysis
by: Qifeng Li, et al.
Published: (2018-06-01) -
Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
by: Tahir Masud, et al.
Published: (2009-11-01) -
Effect of risedronate on bone loss at discontinuation of denosumab
by: Michel Laroche, et al.
Published: (2020-12-01) -
Anterior Percutaneous-Assisted Total Hip Arthroplasty: Surgical Technique and Early Outcomes
by: Kevin A. Lawson, MD, et al.
Published: (2020-12-01) -
Two year follow up of supercapsular percutaneously assisted total hip arthroplasty
by: Andrew Kay, et al.
Published: (2021-05-01)